PMID- 34887185 OWN - NLM STAT- MEDLINE DCOM- 20220314 LR - 20220314 IS - 1873-460X (Electronic) IS - 1056-8727 (Linking) VI - 36 IP - 1 DP - 2022 Jan TI - Fetuin-A to adiponectin ratio is an independent indicator of subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes mellitus. PG - 108102 LID - S1056-8727(21)00326-3 [pii] LID - 10.1016/j.jdiacomp.2021.108102 [doi] AB - AIMS: The purpose of this research was to explore the associations of fetuin-A, adiponectin, and fetuin-A/adiponectin ratio (F/A ratio) with subclinical atherosclerosis as evaluated by carotid intima-media thickness (CIMT) in cases with newly diagnosed type 2 diabetes mellitus (T2DM). METHODS: A total of 283 newly diagnosed T2DM patients were enrolled in this study. Serum fetuin-A and adiponectin levels were determined with an ELISA method. Other clinical and biochemical parameters were also collected. RESULTS: Significant linear increases in waist-to-hip ratio (WHR), systolic blood pressure (SBP), diastolic blood pressure, homoeostasis model assessment of insulin resistance, C-reactive protein (CRP) and F/A ratio, and a significant linear decrease in adiponectin with increasing tertiles of CIMT were observed (P for trends <0.05). However, no significant correlation between fetuin-A and CIMT was detected (P > 0.05). In multivariate logistic regression models, WHR, SBP and F/A ratio were independently correlated with higher CIMT. Receiver operating characteristic curve analysis indicated that F/A ratio had a better predictive power for higher CIMT than adiponectin and fetuin-A, with an area under the curve of 0.802, 0.713 and 0.646, respectively. CONCLUSION: F/A ratio is an independent indicator of subclinical atherosclerosis in patients with newly diagnosed T2DM. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Zhou, Zhongwei AU - Zhou Z AD - Department of Clinical Laboratory, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University), Jiangsu 224001, China. FAU - Chen, Hongmei AU - Chen H AD - Department of Clinical Laboratory, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University), Jiangsu 224001, China. FAU - Sun, Mingzhong AU - Sun M AD - Department of Clinical Laboratory, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University), Jiangsu 224001, China. FAU - Jin, Hao AU - Jin H AD - Department of Blood Transfusion, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University), Yancheng, Jiangsu 224001, China. FAU - Ju, Huixiang AU - Ju H AD - Department of Clinical Laboratory, Yancheng Third People's Hospital (The Sixth Affiliated Hospital of Nantong University), Jiangsu 224001, China. Electronic address: jhxycsy@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20211203 PL - United States TA - J Diabetes Complications JT - Journal of diabetes and its complications JID - 9204583 RN - 0 (Adiponectin) RN - 0 (alpha-2-HS-Glycoprotein) SB - IM MH - Adiponectin MH - *Atherosclerosis/complications/diagnosis MH - Carotid Intima-Media Thickness MH - *Diabetes Mellitus, Type 2/complications/diagnosis MH - Humans MH - Risk Factors MH - alpha-2-HS-Glycoprotein OTO - NOTNLM OT - Adiponectin OT - Carotid intima-media thickness OT - Fetuin-A OT - Fetuin-A/adiponectin ratio OT - Subclinical atherosclerosis OT - Type 2 diabetes mellitus EDAT- 2021/12/11 06:00 MHDA- 2022/03/15 06:00 CRDT- 2021/12/10 05:51 PHST- 2021/09/08 00:00 [received] PHST- 2021/10/31 00:00 [revised] PHST- 2021/11/29 00:00 [accepted] PHST- 2021/12/11 06:00 [pubmed] PHST- 2022/03/15 06:00 [medline] PHST- 2021/12/10 05:51 [entrez] AID - S1056-8727(21)00326-3 [pii] AID - 10.1016/j.jdiacomp.2021.108102 [doi] PST - ppublish SO - J Diabetes Complications. 2022 Jan;36(1):108102. doi: 10.1016/j.jdiacomp.2021.108102. Epub 2021 Dec 3.